Aiming Sun

Aiming Sun

Auto-generated profile, based on publicly available information

Aiming Sun

Chemical Biology Discovery Center, 1510 Clifton Road, Emory University, Atlanta, GA 30322

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

14 January 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JJJianxiong Jiang
Jianxiong Jiang
TGThota Ganesh
Thota Ganesh
YDYuhong Du
Yuhong Du
PTPahk Thepchatri
Pahk Thepchatri
ARAsheebo Rojas
Asheebo Rojas
RDRay Dingledine
Ray Dingledine
Activation of the Gαs-coupled EP2 receptor for prostaglandin E2 (PGE 2 ) promotes cell survival in several models of tissue damage. To advance understanding of EP2 functions, we designed experiments to develop allosteric potentiators of this key prostaglandin receptor. Screens of 292,000 compounds identified 93 that at 20 μM ( i ) potentiated the cAMP response to a low concentration of PGE 2 by > 50%; ( ii ) had no effect on EP4 or β2 adrenergic receptors, the cAMP assay itself, or the parent cell line; and ( iii ) increased the potency of PGE 2 on EP2 receptors at least 3-fold. In aqueous solution, the active compounds are largely present as nanoparticles that appear to serve as active reservoirs for bioactive monomer. From 94 compounds synthesized or purchased, based on the modification of one hit compound, the most active increased the potency of PGE 2 on EP2 receptors 4- to 5-fold at 10 to 20 μM and showed substantial neuroprotection in an excitotoxicity model. These small molecules represent previously undescribed allosteric modulators of a PGE 2 receptor. Our results strongly reinforce the notion that activation of EP2 receptors by endogenous PGE 2 released in a cell-injury setting is neuroprotective.

1 September 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ASAiming Sun
Aiming Sun
NCNizal Chandrakumar
Nizal Chandrakumar
JYJeong-Joong Yoon
Jeong-Joong Yoon
RPRichard K. Plemper
Richard K. Plemper
JSJames P. Snyder
James P. Snyder

1 December 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ASAiming Sun
Aiming Sun
YLYang J. Lu
Yang J. Lu
HHHaipeng Hu
Haipeng Hu
MSMamoru Shoji
Mamoru Shoji
DLDennis C. Liotta
Dennis C. Liotta
JSJim Snyder
Jim Snyder

5 April 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JNJ. Maina Ndungu
J. Maina Ndungu
SKStefanie A. Krumm
Stefanie A. Krumm
DYDan Yan
Dan Yan
RARichard F. Arrendale
Richard F. Arrendale
GRG. Prabhakar Reddy
G. Prabhakar Reddy
ASAiming Sun
Aiming Sun

31 December 2009 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
ILIgor Landais
Igor Landais
SHSanne Hiddingh
Sanne Hiddingh
MMMatthew McCarroll
Matthew McCarroll
CYChao Yang
Chao Yang
ASAiming Sun
Aiming Sun
MHMaureen E Hoatlin
Maureen E Hoatlin
Background: The Fanconi anemia (FA) pathway is a multigene DNA damage response network implicated in the repair of DNA lesions that arise during replication or after exogenous DNA damage. The FA pathway displays synthetic lethal relationship with certain DNA repair genes such as ATM (Ataxia Telangectasia Mutated) that are frequently mutated in tumors. Thus, inhibition of FANCD2 monoubiquitylation (FANCD2-Ub), a key step in the FA pathway, might target tumor cells defective in ATM through synthetic lethal interaction. Curcumin was previously identified as a weak inhibitor of FANCD2-Ub. The aim of this study is to identify derivatives of curcumin with better activity and specificity. Results: Using a replication-free assay in Xenopus extracts, we screened monoketone analogs of curcumin for inhibition of FANCD2-Ub and identified analog EF24 as a strong inhibitor. Mechanistic studies suggest that EF24 targets the FA pathway through inhibition of the NF-kB pathway kinase IKK. In HeLa cells, nanomolar concentrations of EF24 inhibited hydroxyurea (HU)-induced FANCD2-Ub and foci in a cell-cycle independent manner. Survival assays revealed that EF24 specifically sensitizes FA-competent cells to the DNA crosslinking agent mitomycin C (MMC). In addition, in contrast with curcumin, ATM-deficient cells are twofold more sensitive to EF24 than matched wild-type cells, consistent with a synthetic lethal effect between FA pathway inhibition and ATM deficiency. An independent screen identified 4H-TTD, a compound structurally related to EF24 that displays similar activity in egg extracts and in cells. Conclusions: These results suggest that monoketone analogs of curcumin are potent inhibitors of the FA pathway and constitute a promising new class of targeted anticancer compounds.